Canadian Cardiovascular Society/Canadian Association ofInterventional Cardiology/Canadian Society of CardiacSurgery Position Statement on Revascularization-Multivessel Coronary Artery Disease

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1482-1491

  Teo, Koon K ^a   Cohen, Eric ^b   Buller, Christopher ^c   Hassan, Ansar ^d   Carere, Ronald ^e   Cox, Jafna L ^f   Ly, Hung ^g   Fedak, Paul W ^h   Chan, Kwan ⁱ   Légaré, Jean Francois ^f   Connelly, Kim ^c   Tanguay, Jean Francois ^g   Ye, Jian ^e   Gupta, Milan ^j   John Mancini, G B ^e   Dagenais, Gilles ^k   Williams, Randall ^l   Teoh, Kevin ^j   Latter, David A ^c   Townley, Richard ^m   Meyer, Steven R ^l   more..

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d SAINT JOHN REGIONAL HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g MONTREAL HEART INSTITUTE   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k LAVAL UNIVERSITY   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

^m Interior Health Authority   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ACUTE CORONARY SYNDROME; ARTICLE; CANADA; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; EUROSCORE; EVIDENCE BASED PRACTICE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL SOCIETY; MORTALITY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYNTAX SCORE; TREATMENT OUTCOME; CARDIOLOGY; STANDARDS;

CANADA; CARDIOLOGY; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84919768268     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.09.034     Document Type: Article

References (46)

1. Heart & Stroke Foundation. Available at: . Accessed January 10, 2014. http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.F922/Heart_Disease_Stroke_and_Healthy_Living.htm.
2. Fitchett D.H., Theroux P., Brophy J.M., et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment-part 2: ST-segment elevation myocardial infarction. Can J Cardiol 2011, 27(suppl A):S402-S412.
3. O'Donoghue M., Boden W.E., Braunwald E., et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008, 300:71-80.
4. Wald D.S., Morris J.K., Wald N.J., et al. Randomized trial of preventive angioplasty in myocardial infarction. NEngl J Med 2013, 369:1115-1123.
5. Corpus R.A., House J.A., Marso S.P., et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004, 148:493-500.
6. Kong J.A., Chou E.T., Minutello R.M., Wong S.C., Hong M.K. Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: report from the New York State Angioplasty Registry. Coron Artery Dis 2006, 17:71-75.
7. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344:563-570.
8. Katritsis D.G., Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005, 111:2906-2912.
9. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. NEngl J Med 2007, 356:1503-1516.
10. Dagenais G.R., Lu J., Faxon D.P., et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011, 123:1492-1500.
11. Hlatky M.A., Boothroyd D.B., Bravata D.M., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009, 373:1190-1197.
12. Weintraub W.S., Grau-Sepulveda M.V., Weiss J.M., et al. Comparative effectiveness of revascularization strategies. NEngl J Med 2012, 366:1467-1476.
13. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. NEngl J Med 2009, 360:961-972.
14. Mohr F.W., Morice M.C., Kappetein A.P., et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013, 381:629-638.
15. Farkouh M.E., Domanski M., Sleeper L.A., et al. Strategies for multivessel revascularization in patients with diabetes. NEngl J Med 2012, 367:2375-2384.
16. Harskamp R.E., Zheng Z., Alexander J.H., et al. Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease. Ann Thorac Surg 2013, 96:2268-2277.
17. Velazquez E.J., Lee K.L., Deja M.A., et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011, 364:1607-1616.
18. Morrison D.A., Sethi G., Sacks J., et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). JAm Coll Cardiol 2001, 38:143-149.
19. Rouleau J.L., Bonow R.O. An approach to the rational use of revascularization in heart failure patients. Can J Cardiol 2014, 30:281-287.
20. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013, 128:1810-1852.
21. Moe G.W., Ezekowitz J.A., O'Meara E., et al. The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization. Can J Cardiol 2014, 30:249-263.
22. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
23. Panza J.A., Holly T.A., Asch F.M., et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. JAm Coll Cardiol 2013, 61:1860-1870.
24. Morice M.C., Serruys P.W., Kappetein A.P., et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010, 121:2645-2653.
25. Capodanno D., Stone G.W., Morice M.C., Bass T.A., Tamburino C. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. JAm Coll Cardiol 2011, 58:1426-1432.
26. Alam M., Huang H.D., Shahzad S.A., et al. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era-an aggregate data meta-analysis of 11,148 patients. Circ J 2013, 77:372-382.
27. Farooq V., van Klaveren D., Steyerberg E.W., et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013, 381:639-650.
28. Verma S., Farkouh M.E., Yanagawa B., et al. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol 2013, 1:317-328.
29. Shahian D.M., O'Brien S.M., Filardo G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 2009, 88:S2-22.
30. Hemmelgarn B.R., Southern D., Culleton B.F., et al. Survival after coronary revascularization among patients with kidney disease. Circulation 2004, 110:1890-1895.
31. Wang Z.J., Zhou Y.J., Liu Y.Y., et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J 2009, 73:1228-1234.
32. Ix J.H., Mercado N., Shlipak M.G., et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005, 149:512-519.
33. Frye R.L., August P., Brooks M.M., et al. Arandomized trial of therapies for type 2 diabetes and coronary artery disease. NEngl J Med 2009, 360:2503-2515.
34. Selvaraj C.L., Gurm H.S., Gupta R., Ellis S.G., Bhatt D.L. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2005, 96:756-759.
35. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: a call to action. JAm Med Dir Assoc 2013, 14:392-397.
36. Afilalo J. Frailty in patients with cardiovascular disease: why, when, and how to measure. Curr Cardiovasc Risk Rep 2011, 5:467-472.
37. Ekerstad N., Swahn E., Janzon M., et al. Frailty is independently associated with 1-year mortality for elderly patients with non-ST-segment elevation myocardial infarction. Eur J Prev Cardiol 2014, 21:1216-1224.
38. Lee D.H., Buth K.J., Martin B.J., Yip A.M., Hirsch G.M. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation 2010, 121:973-978.
39. Graham M.M., Galbraith P.D., O'Neill D., et al. Frailty and outcome in elderly patients with acute coronary syndrome. Can J Cardiol 2013, 29:1610-1615.
40. Afilalo J., Alexander K.P., Mack M.J., et al. Frailty assessment in the cardiovascular care of older adults. JAm Coll Cardiol 2014, 63:747-762.
41. Head S.J., Kaul S., Mack M.J., et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 2013, 34:2510-2518.
42. Nashef S.A., Roques F., Sharples L.D., et al. EuroSCORE II. Eur J Cardiothorac Surg 2012, 41:734-744. discussion 744-5.
43. Puskas J.D., Kilgo P.D., Thourani V.H., et al. The society of thoracic surgeons 30-day predicted risk of mortality score also predicts long-term survival. Ann Thorac Surg 2012, 93:26-33. discussion 33-5.
44. Paparella D., Guida P., Di Eusanio G., et al. Risk stratification for in-hospital mortality after cardiac surgery: external validation of EuroSCORE II in a prospective regional registry. Eur J Cardiothorac Surg 2014, 46:840-848.
45. Afilalo J., Mottillo S., Eisenberg M.J., et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes 2012, 5:222-228.
46. Windecker S, Kolh P, Alfonso F, etal. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) [e-pub ahead of print]. Eur Heart J . Accessed September 21, 2014. doi:10.1093/eurheart/ehu278.